Zoetis, Inc. Class A (ZTS)

145.68
NYSE
Prev Close 144.00
Day Low/High 141.41 / 146.04
52 Wk Low/High 90.14 / 176.64
Exchange NYSE
Shares Outstanding 475.17B
Market Cap 68.42B
P/E Ratio 47.07
Div & Yield N.A. (N.A)
Cramer: Whole Foods Is 'Show Me' Stock Now, Wait on Kinder Morgan

Cramer: Whole Foods Is 'Show Me' Stock Now, Wait on Kinder Morgan

Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.

Weekly Bull Chart: Zoetis

Weekly Bull Chart: Zoetis

If you were only looking for one reason to buy, price would be it.

Breakout Extends Healthy Rally for Zoetis

Breakout Extends Healthy Rally for Zoetis

Moving past resistance, there's plenty of upside potential.

Zoetis downgraded at JP Morgan

There's a Lot Going on Under the Hood

An immense market rotation is happening.

Zoetis price target raised at Jefferies

Cramer: When Can a Solid CEO Catch a Break?

I expect better from grown-up hedge fund managers.

Zoetis downgraded at William Blair

13-F Filings Reveal Funds Buying Alibaba, Cutting Apple Positions

13-F Filings Reveal Funds Buying Alibaba, Cutting Apple Positions

In 13-F filings with the Securities and Exchange Commission, Daniel Loeb's Third Point, Soros Fund Management, and other large fund managers disclosed big stakes in Chinese e-commerce giant Alibaba.

Consider Drug Stocks for Animals

Bill Ackman is betting on Zoetis -- and you should, too.

Paradise Lost

Whatever you pick, it is hard to keep up with the S&P 500.

The Difference Between Europe and Us

The Difference Between Europe and Us

Our market's been a terrific place to invest while Europe withers.

A View of Value Investing From Abroad

A View of Value Investing From Abroad

At a London conference, these two U.S. companies get some attention.

Kindred Bio CEO: Expect 3 Dynamic Dog Drugs by 2015

Kindred Bio CEO: Expect 3 Dynamic Dog Drugs by 2015

Kindred Biosciences stock has more than doubled since it started trading in December, but the company's employees are hard at work developing its osteoarthritis drug.

A Nutty Environment

A Nutty Environment

Sometimes the facts just don't fit the story.

Zoetis downgraded at Morgan Stanley

Going Past the IPO Hype

Going Past the IPO Hype

These three companies can add balance to portfolios.

Get Your Portfolio Into the Bunker

Get Your Portfolio Into the Bunker

Solid yielders like these should provide some much-needed cushion in the coming days.

Zoetis upgraded at Morgan Stanley

Steve Cohen's Best Ideas

Steve Cohen's Best Ideas

Can't pick his brain? Look at his top five holdings instead.

Zoetis Zeroing In On China, Brazil

Zoetis Zeroing In On China, Brazil

Newly spun-off from Pfizer, Zoetis has big plans for its animal health business in the emerging markets, says the company's CEO Juan Ramon Alaix.

Zoetis upgraded at BofA/Merrill

Zoetis upgraded at BMO

Zoetis upgraded at BMO

Stock Picks for Pet Lovers

Stock Picks for Pet Lovers

These name capitalize on the trend of spending on our pets, which has become recession proof.

Zoetis initiated at Neutral at Goldman

Zoetis rated new Neutral at BofA/Merrill

Zoetis rated new Underperform at BMO